Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Invested Capital (2017 - 2026)

Corcept Therapeutics (CORT) has disclosed Return on Invested Capital for 10 consecutive years, with 0.05% as the latest value for Q1 2026.

  • For Q1 2026, Return on Invested Capital fell 21.0% year-over-year to 0.05%; the TTM value through Mar 2026 reached 0.05%, down 21.0%, while the annual FY2025 figure was 0.1%, 10.0% down from the prior year.
  • Return on Invested Capital hit 0.05% in Q1 2026 for Corcept Therapeutics, down from 0.1% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.28% in Q1 2022 and bottomed at 0.05% in Q1 2026.
  • Average Return on Invested Capital over 5 years is 0.18%, with a median of 0.18% recorded in 2024.
  • Year-over-year, Return on Invested Capital grew 10bps in 2022 and then dropped -21bps in 2026.
  • Corcept Therapeutics' Return on Invested Capital stood at 0.2% in 2022, then fell by -6bps to 0.19% in 2023, then fell by -4bps to 0.18% in 2024, then tumbled by -42bps to 0.1% in 2025, then tumbled by -148bps to 0.05% in 2026.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.05%, 0.1%, and 0.12% for Q1 2026, Q4 2025, and Q3 2025 respectively.